Rchr
J-GLOBAL ID:200901097026918083   Update date: Jul. 20, 2021

Kei Nakajima

ナカジマ ケイ | Kei Nakajima
Affiliation and department:
Job title: Clinical Assistant Professor
Homepage URL  (1): http://www.yamanashi-hematology.com/
Research field  (1): Hematology and oncology
Research keywords  (2): 低酸素応答/骨髄増殖性疾患/骨髄線維化 ,  悪性リンパ腫 / 解糖系 / へキソキナーゼ / NF-κB / 抗がん剤耐性
Research theme for competitive and other funds  (3):
  • 2019 - 2022 悪性リンパ腫における腫瘍性糖代謝とNF-κΒ活性化のクロストークの検証
  • 2019 - 2022 悪性リンパ腫における腫瘍性糖代謝とNF-κΒ活性化のクロストークの検証
  • 2012 - 2015 Hypoxia modulate epigenomic response in MPN cells
Papers (9):
  • 松浦 未乃莉, 輿石 めぐみ, 鈴木 潤, 鈴木 愛, 川島 一郎, 中嶌 圭, 桐戸 敬太, 著者情報. 多彩な自己免疫異常と骨髄線維症を併発した血管免疫芽球性T細胞リンパ腫. 臨床血液. 2020. 61. 2. 110-115
  • Nakajima K, Kawashima I, Koshiisi M, Kumagai T, Suzuki M, Suzuki J, Mitsumori T, Kirito K. Glycolytic enzyme hexokinase II is a putative therapeutic target in B-cell malignant lymphoma. Experimental hematology. 2019. 78. Oct 2019. 46-55
  • Ichiro Kawashima, Hiroko Fukasawa, Kazunari Kasai, Takuma Kumagai, Megumi Koshiishi, Kei Nakajima, Tetsuo Kondo, Akihiko Hashi, Shuji Hirata, Keita Kirito. Bone Marrow Invasion of Small Cell Neuroendocrine Carcinoma of the Endometrium: A Diagnostic Pitfall Mimicking a Haematological Malignancy. INTERNAL MEDICINE. 2019. 58. 17. 2561-2568
  • Kawashima I, Kumagai T, Suzuki M, Suzuki J, Koshiishi M, Nakajima K, Kirito K. Molecular response of CSF3R T618I harboring chronic neutrophilic leukemia after induction chemotherapy linked to cord blood transplantation. Ann Hematol. 2019. 98. 9. 2249-2250
  • Ichiro Kawashima, Katsuhiro Takano, Takuma Kumagai, Megumi Koshiishi, Saori Oishi, Yuki Sueki, Kei Nakajima, Toru Mitsumori, Keita Kirito. Combined Coagulopathy Can Induce Both Hemorrhagic and Thrombotic Complications in Multiple Myeloma. INTERNAL MEDICINE. 2018. 57. 22. 3303-3306
more...
Lectures and oral presentations  (4):
  • Efficacy of rasburicase in patients with multiple myeloma who received bortezomib based chemotherapy
    (第18回日本臨床腫瘍学会学術集会 2021)
  • Aberrant regulation of extracellular matrix homeostasis by JAK2V617F
    (JSH2020 2020)
  • Aberrant Activation of NF-κB and Hypoxia Enhances Glycolytic Enzyme Hexokinase II Expression in B-Cell Lymphoma through Activation of HIF-1
    (ASH annual meeting 2017 2017)
  • Panobinostat reverses hypoxia-induced hexokinase2- dependent cisplatin resistance in lymphoma cells
    (JSH2017 2017)
Education (2):
  • - 2019 University of Yamanashi 先進医療科専攻
  • 1998 - 2004 富山医科薬科大学 医学科
Professional career (2):
  • 医学士 (富山医科薬科大学)
  • 博士(医学) (山梨大学)
Work history (5):
  • 2019/04/01 - 山梨大学医学部附属病院 腫瘍センター 臨床助教
  • 2018/04/01 - 2019/03/31 University of Yamanashi (Blood and Medical Oncology Course (Blood and Medical Oncology)) 血液・腫瘍内科 助教
  • 2006/10 - 山梨大学医学部附属病院 血液・腫瘍内科 医員
  • 2006/04 - 2006/09 財団法人身延山病院 内科 医員
  • 2004/04 - 2006/03 山梨大学医学部附属病院 卒後臨床研修センター
Association Membership(s) (4):
日本内科学会 ,  日本血液学会 ,  日本臨床腫瘍学会 ,  日本造血細胞移植学会
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page